Literature DB >> 8532649

Distal pancreatectomy for cancer: results in U.S. Department of Veterans Affairs hospitals, 1987-1991.

T P Wade1, K S Virgo, F E Johnson.   

Abstract

Although cancers of the pancreatic body and tail are often advanced at the time of diagnosis, resection of localized tumors can result in long-term survival. A search of the computerized records of the U.S. Department of Veterans Affairs (DVA) revealed 29 distal pancreatectomies performed for pancreatic cancer from 1987 to 1991. Operative complications and survival data were available on all patients, and pathologic and staging information were retrieved on 21 patients, seven of whom had cancers other than pancreatic adenocarcinoma. Although 30-day mortality was high after distal pancreatectomy (21%), mean survival exceeded 1 year for patients with localized pancreatic adenocarcinoma and for those with histologies other than pancreatic cancer. Surgical resection should be offered to patients with lesions of the pancreatic body and tail when metastases are not demonstrated; survival will likely be prolonged when nodal or systemic metastases are absent. These recent DVA results from a wide variety of surgeons, hospital sizes, and university affiliations may more closely reflect the national experience with this operation in patients with cancer than do single institutional reports.

Entities:  

Mesh:

Year:  1995        PMID: 8532649

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  9 in total

1.  Distal pancreatectomy associated with multivisceral resection: results from a single centre experience.

Authors:  Francesca Panzeri; Giovanni Marchegiani; Giuseppe Malleo; Anna Malpaga; Laura Maggino; Tiziana Marchese; Roberto Salvia; Claudio Bassi; Giovanni Butturini
Journal:  Langenbecks Arch Surg       Date:  2016-10-27       Impact factor: 3.445

2.  Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splenectomy.

Authors:  Paul Toomey; Jonathan Hernandez; Farhaad Golkar; Sharona Ross; Kenneth Luberice; Alexander Rosemurgy
Journal:  J Gastrointest Surg       Date:  2011-12-02       Impact factor: 3.452

3.  The anatomic location of pancreatic cancer is a prognostic factor for survival.

Authors:  Avo Artinyan; Perry A Soriano; Christina Prendergast; Tracey Low; Joshua D I Ellenhorn; Joseph Kim
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

4.  Curative resection for left-sided pancreatic malignancy.

Authors:  Magnus Bergenfeldt; Flemming Moesgaard; Flemming Burcharth
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

5.  Perioperative mortality for pancreatectomy: a national perspective.

Authors:  James T McPhee; Joshua S Hill; Giles F Whalen; Maksim Zayaruzny; Demetrius E Litwin; Mary E Sullivan; Frederick A Anderson; Jennifer F Tseng
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

6.  Clinical impact of preoperative endoscopic ultrasound-guided fine-needle aspiration for pancreatic ductal adenocarcinoma.

Authors:  Hideharu Tsutsumi; Kazuo Hara; Nobumasa Mizuno; Susumu Hijioka; Hiroshi Imaoka; Masahiro Tajika; Tsutomu Tanaka; Makoto Ishihara; Kenichi Yoshimura; Yasuhiro Shimizu; Yasumasa Niwa; Yutaka Sasaki; Kenji Yamao
Journal:  Endosc Ultrasound       Date:  2016 Mar-Apr       Impact factor: 5.628

Review 7.  Pancreatic Cancer: 80 Years of Surgery-Percentage and Repetitions.

Authors:  Birgir Gudjonsson
Journal:  HPB Surg       Date:  2016-10-25

8.  Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer.

Authors:  Zhenjiang Zheng; Mojin Wang; Chunlu Tan; Yonghua Chen; Jie Ping; Rui Wang; Xubao Liu
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

9.  The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer.

Authors:  Mirang Lee; Wooil Kwon; Hongbeom Kim; Yoonhyeong Byun; Youngmin Han; Jae Seung Kang; Yoo Jin Choi; Jin-Young Jang
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.